Karah Herdman Parschauer, EVP and Chief Legal Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 9,806 shares at $45.00 ($441K) on 2024-06-12, disclosed to the SEC on 2024-06-12.
Scheduled sale ($441k) by EVP and Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RARE | SELL | 2026-03-10 | $208K | — | Filing → |
| RARE | SELL | 2026-03-03 | $185K | — | Filing → |
| RARE | SELL | 2025-09-12 | $153K | — | Filing → |